Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Apr 22, 2019
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-04-22$11.08/sh+1,250$13,853→ 1,250 total
4 · Eiger BioPharmaceuticals, Inc. · Filed Apr 22, 2019
Common Stock